ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage-Reference-Cited by-同舟云学术

ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage

Published:2017-08-08 Issue:20 Volume:77 Page:5576-5590
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Perkhofer Lukas,Schmitt Anna,Romero Carrasco Maria Carolina,Ihle Michaela,Hampp Stephanie,Ruess Dietrich Alexander,Hessmann Elisabeth,Russell Ronan,Lechel André,Azoitei Ninel,Lin Qiong,Liebau Stefan,Hohwieler Meike,Bohnenberger Hanibal,Lesina Marina,Algül Hana,Gieldon Laura,Schröck Evelin,Gaedcke Jochen,Wagner Martin,Wiesmüller Lisa,Sipos Bence,Seufferlein Thomas,Reinhardt Hans Christian,Frappart Pierre-Olivier,Kleger Alexander

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibitor synthetic lethality in ATM biallelic mutant cancer cell lines is associated with BRCA1/2 and RAD51 downregulation;Frontiers in Oncology;2024-05-14

2. Somatic Mutational Analysis in Endoscopic Ultrasound–Guided Biopsy of Pancreatic Adenocarcinoma: Assessing Yield and Impact;American Journal of Gastroenterology;2024-04-18

3. A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations;Diagnostic Pathology;2024-01-06

4. Synergistic antitumor efficacy of rMV-Hu191 and Olaparib in pancreatic cancer by generating oxidative DNA damage and ROS-dependent apoptosis;Translational Oncology;2024-01

5. Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma;Journal of Cancer;2024